Friday, March 6, 2026
Home Authors Posts by Ogkologos

Ogkologos

4160 POSTS 0 COMMENTS

Adding Hormone Therapy to PORT Might Not Benefit Patients with Recurrent...

Ogkologos -
0

FDA Approves Acalabrutinib with Venetoclax for CLL or SLL

Ogkologos -
0

No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with...

Ogkologos -
0

Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation...

Ogkologos -
0

Rare Disease Day 2026: Advancing equity for people living with rare...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Ponatinib

Ogkologos -
0

Screening Programme by Primary Colonoscopy or Two Rounds of Two-Stool FIT...

Ogkologos -
0

Updated Oncogene-Addicted mNSCLC Living Guideline v1.3

Ogkologos -
0

FDA Approves Pembrolizumab with Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube,...

Ogkologos -
0

Nivolumab Plus Chemotherapy Continues to Demonstrate Long-Term Survival Benefits in Patients...

Ogkologos -
0
123...416Page 1 of 416

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com